Casa Santa Isabel — Rosarito, Mexico

Casa Santa Isabel is an ibogaine treatment clinic located in Rosarito, Baja California, Mexico. The facility describes itself as one of the most credentialed ibogaine providers in Mexico, holding memberships and accreditations from the Asociación de Hospitales de Baja California, CANACINTRA (Mexico's national chamber of industry), and the American Heart Association. The clinic also claims to be the only certified ibogaine facility in Mexico operating with an in-house pharmacy and laboratory.

What the Clinic Treats

  • Heroin, opioid, and fentanyl addiction
  • Methamphetamine and cocaine addiction
  • Alcohol addiction
  • Depression and anxiety
  • ADHD

What to Expect

Casa Santa Isabel reports medical supervision on-site, with staff described as ALS (Advanced Life Support) certified. The presence of an in-house pharmacy and lab is notable, as it may allow for faster on-site testing and medication management compared to facilities that rely on external resources. Ibogaine treatment for opioid and stimulant addiction typically involves a medically monitored administration period, preparation protocols, and follow-up care — prospective patients should ask specifically what each phase of their program includes.

Pricing is not publicly listed. The clinic directs inquiries to a cost estimator tool; contact the facility directly for a personalized quote.

Before You Commit — Research Carefully

  1. Cardiac screening: This clinic does not list cardiac screening as a standard offering. Ibogaine carries well-documented cardiac risks, including QT interval prolongation. Ask explicitly whether an ECG and cardiac clearance are part of their pre-treatment protocol.
  2. Verify accreditations: Confirm current standing with each listed body independently, as accreditations can lapse or change.
  3. Aftercare planning: Ask what structured aftercare or referral support is provided following treatment.
  4. Staffing credentials: Request documentation of staff qualifications and on-call physician availability during treatment sessions.
Ibogaine carries serious cardiac risks and is not approved by the FDA. Anyone with a cardiac history, on medications that affect heart rhythm, or using opioids should seek thorough medical evaluation before considering ibogaine treatment.